Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naive CLL/SLL. Narkhede MS, Blau S, Peevyhouse A, Neuhalfen H, et al. Leuk Lymphoma 2026;67:2106-2115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Narkhede MS, Blau S, Peevyhouse A, Neuhalfen H, et al. Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naive CLL/SLL. Leuk Lymphoma 2026;67:2106-2115.
PMID: 42340892